Oxford University COVID-19 vaccine human trials enter advanced phase

44

New Delhi: The Oxford University has embarked on coronavirus vaccine trials on humans on an advanced phase, according to reports.

The University of Oxford said that the researchers have begun recruiting adults and children for advanced human trials of the vaccine. The trials will involve up to 10,260 volunteers across the UK.

The  first phase of trials began in April with about 1,000 volunteers. The results of the first trial were completed and are now under a follow-up. The advanced trial phase will have phase 2 and phase 3 trials of the vaccine.

This trial phase will help researchers understand how the vaccine produces an immune response in bodies of different age groups.

Leave A Reply

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.